Aspirin demonstrates similar protective effects on prevention of VTE compared to other agents and may have significant protective effects on overall mortality following surgical intervention for hip fractures. However, the current evidence concerning its use in this arena is less than robust, with more than half of the studied outcomes considered statistically fragile.
Keyphrases
- venous thromboembolism
- hip fracture
- cardiovascular events
- low dose
- direct oral anticoagulants
- antiplatelet therapy
- randomized controlled trial
- minimally invasive
- coronary artery bypass
- coronary artery disease
- risk factors
- anti inflammatory drugs
- percutaneous coronary intervention
- acute coronary syndrome
- surgical site infection
- adipose tissue
- skeletal muscle